Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France

CONTEXT: Prospective studies have demonstrated the efficacy of osilodrostat in Cushing disease. No study has evaluated osilodrostat in a series of patients with paraneoplastic Cushing syndrome/ectopic adrenocorticotropin syndrome (PNCS/EAS). OBJECTIVE: This work aimed to evaluate in France the real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Dormoy, Alexandre, Haissaguerre, Magalie, Vitellius, Géraldine, Do Cao, Christine, Geslot, Aurore, Drui, Delphine, Lasolle, Hélène, Vieira-Pinto, Oceana, Salenave, Sylvie, François, Maud, Puerto, Marie, Boullay, Hélène Du, Mayer, Anne, Rod, Anne, Laurent, Claire, Chanson, Philippe, Reznik, Yves, Castinetti, Frédéric, Chabre, Olivier, Baudin, Eric, Raverot, Gérald, Tabarin, Antoine, Young, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188310/
https://www.ncbi.nlm.nih.gov/pubmed/36470583
http://dx.doi.org/10.1210/clinem/dgac691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188310/
https://www.ncbi.nlm.nih.gov/pubmed/36470583
http://dx.doi.org/10.1210/clinem/dgac691

Ejemplares similares